Time course of immature platelet count and its relation to thrombocytopenia and mortality in patients with sepsis

PLoS ONE

Volumn 13, Issue 1, 2018, Pages

  Koyama, Kansuke ^a   Katayama, Shinshu ^a   Muronoi, Tomohiro ^a   Tonai, Ken ^a   Goto, Yuya ^a   Koinuma, Toshitaka ^a   Shima, Jun ^a   Nunomiya, Shin ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ABSOLUTE IMMATURE PLATELET COUNT; AGED; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NADIR PLATELET COUNT; OBSERVATIONAL STUDY; PATHOGENESIS; PLATELET COUNT; RETROSPECTIVE STUDY; SEPSIS; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS; UNIVERSITY HOSPITAL; COMPLICATION; MIDDLE AGED; PATHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET COUNT; RETROSPECTIVE STUDIES; SEPSIS; THROMBOCYTOPENIA;

EID: 85041176924     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0192064     Document Type: Article

References (45)

1. Sharma B, Sharma M, Majumder M, Steier W, Sangal A, Kalawar M. Thrombocytopenia in septic shock patients—a prospective observational study of incidence, risk factors and correlation with clinical outcome. Anaesth Intensive Care. 2007; 35(6):874–80. PMID: 18084977
2. Larkin CM, Santos-Martinez MJ, Ryan T, Radomski MW. Sepsis-associated thrombocytopenia. Thromb Res. 2016; 141:11–6. https://doi.org/10.1016/j.thromres.2016.02.022 PMID: 26953822
3. Martin CM, Priestap F, Fisher H, Fowler RA, Heyland DK, Keenan SP, et al. A prospective, observational registry of patients with severe sepsis: the Canadian Sepsis Treatment and Response Registry. Crit Care Med. 2009; 37(1):81–8. https://doi.org/10.1097/CCM.0b013e31819285f0 PMID: 19050636
4. Vanderschueren S, De Weerdt A, Malbrain M, Vankersschaever D, Frans E, Wilmer A, et al. Thrombocytopenia and prognosis in intensive care. Crit Care Med. 2000; 28(6):1871–6. PMID: 10890635
5. Moreau D, Timsit JF, Vesin A, Garrouste-Orgeas M, de Lassence A, Zahar JR, et al. Platelet count decline: an early prognostic marker in critically ill patients with prolonged ICU stays. Chest. 2007; 131 (6):1735–41. https://doi.org/10.1378/chest.06-2233 PMID: 17475637
6. Thiery-Antier N, Binquet C, Vinault S, Meziani F, Boisrame-Helms J, Quenot JP, et al. Is Thrombocytopenia an Early Prognostic Marker in Septic Shock? Crit Care Med. 2016; 44(4):764–72.
7. Vandijck DM, Blot SI, De Waele JJ, Hoste EA, Vandewoude KH, Decruyenaere JM. Thrombocytopenia and outcome in critically ill patients with bloodstream infection. Heart Lung. 2010; 39(1):21–6. https://doi.org/10.1016/j.hrtlng.2009.07.005 PMID: 20109983
8. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996; 22(7):707–10. PMID: 8844239
9. Taylor FB Jr., Toh CH, Hoots WK, Wada H, Levi M, Scientific Subcommittee on Disseminated Intravas-cular Coagulation of the International Society on T, et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001; 86 (5):1327–30. PMID: 11816725
10. Gando S, Iba T, Eguchi Y, Ohtomo Y, Okamoto K, Koseki K, et al. A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria. Crit Care Med. 2006; 34(3):625–31. PMID: 16521260
11. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315(8):801–10. https://doi.org/10.1001/jama.2016.0287 PMID: 26903338
12. Vincent JL, Yagushi A, Pradier O. Platelet function in sepsis. Crit Care Med. 2002; 30(5 Suppl):S313–7. PMID: 12004253
13. de Stoppelaar SF, van’t Veer C, van der Poll T. The role of platelets in sepsis. Thromb Haemost. 2014; 112(4):666–77. https://doi.org/10.1160/TH14-02-0126 PMID: 24966015
14. Koyama K, Madoiwa S, Tanaka S, Koinuma T, Wada M, Sakata A, et al. Evaluation of hemostatic biomarker abnormalities that precede platelet count decline in critically ill patients with sepsis. J Crit Care. 2013; 28(5):556–63. https://doi.org/10.1016/j.jcrc.2012.10.069 PMID: 23583072
15. Semeraro N, Ammollo CT, Semeraro F, Colucci M. Sepsis, thrombosis and organ dysfunction. Thromb Res. 2012; 129(3):290–5. https://doi.org/10.1016/j.thromres.2011.10.013 PMID: 22061311
16. Taylor FB Jr., Wada H, Kinasewitz G. Description of compensated and uncompensated disseminated intravascular coagulation (DIC) responses (non-overt and overt DIC) in baboon models of intravenous and intraperitoneal Escherichia coli sepsis and in the human model of endotoxemia: toward a better definition of DIC. Crit Care Med. 2000; 28(9 Suppl):S12–9. PMID: 11007191
17. Deutsch VR, Tomer A. Advances in megakaryocytopoiesis and thrombopoiesis: from bench to bedside. Br J Haematol. 2013; 161(6):778–93. https://doi.org/10.1111/bjh.12328 PMID: 23594368
18. Thiolliere F, Serre-Sapin AF, Reignier J, Benedit M, Constantin JM, Lebert C, et al. Epidemiology and outcome of thrombocytopenic patients in the intensive care unit: results of a prospective multicenter study. Intensive Care Med. 2013; 39(8):1460–8. https://doi.org/10.1007/s00134-013-2963-3 PMID: 23740274
19. Abe Y, Wada H, Tomatsu H, Sakaguchi A, Nishioka J, Yabu Y, et al. A simple technique to determine thrombopoiesis level using immature platelet fraction (IPF). Thromb Res. 2006; 118(4):463–9. https://doi.org/10.1016/j.thromres.2005.09.007 PMID: 16253312
20. Briggs C, Kunka S, Hart D, Oguni S, Machin SJ. Assessment of an immature platelet fraction (IPF) in peripheral thrombocytopenia. Br J Haematol. 2004; 126(1):93–9. https://doi.org/10.1111/j.1365-2141.2004.04987.x PMID: 15198738
21. Pons I, Monteagudo M, Lucchetti G, Munoz L, Perea G, Colomina I, et al. Correlation between immature platelet fraction and reticulated platelets. Usefulness in the etiology diagnosis of thrombocytopenia. Eur J Haematol. 2010; 85(2):158–63. https://doi.org/10.1111/j.1600-0609.2010.01468.x PMID: 20477866
22. Takami A, Shibayama M, Orito M, Omote M, Okumura H, Yamashita T, et al. Immature platelet fraction for prediction of platelet engraftment after allogeneic stem cell transplantation. Bone Marrow Transplant. 2007; 39(8):501–7. https://doi.org/10.1038/sj.bmt.1705623 PMID: 17334382
23. Barsam SJ, Psaila B, Forestier M, Page LK, Sloane PA, Geyer JT, et al. Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia. Blood. 2011; 117(21):5723–32. https://doi.org/10.1182/blood-2010-11-321398 PMID: 21389318
24. Hoffmann JJ. Reticulated platelets: analytical aspects and clinical utility. Clin Chem Lab Med. 2014; 52(8):1107–17. https://doi.org/10.1515/cclm-2014-0165 PMID: 24807169
25. Kulshrestha M, Sola-Visner M, Widness JA, Veng-Pedersen P, Mager DE. Mathematical model of platelet turnover in thrombocytopenic and nonthrombocytopenic preterm neonates. Am J Physiol Heart Circ Physiol. 2015; 308(1):H68–73. https://doi.org/10.1152/ajpheart.00528.2013 PMID: 25362135
26. Muronoi T, Koyama K, Nunomiya S, Lefor AK, Wada M, Koinuma T, et al. Immature platelet fraction predicts coagulopathy-related platelet consumption and mortality in patients with sepsis. Thromb Res. 2016; 144:169–75. https://doi.org/10.1016/j.thromres.2016.06.002 PMID: 27380496
27. De Blasi RA, Cardelli P, Costante A, Sandri M, Mercieri M, Arcioni R. Immature platelet fraction in predicting sepsis in critically ill patients. Intensive Care Med. 2013; 39(4):636–43. https://doi.org/10.1007/ s00134-012-2725-7 PMID: 23093245
28. Di Mario A, Garzia M, Leone F, Arcangeli A, Pagano L, Zini G. Immature platelet fraction (IPF) in hospitalized patients with neutrophilia and suspected bacterial infection. J Infect. 2009; 59(3):201–6. https://doi.org/10.1016/j.jinf.2009.07.007 PMID: 19647322
29. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013; 39(2):165–228. https://doi.org/10.1007/s00134-012-2769-8 PMID: 23361625
30. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985; 13(10):818–29. PMID: 3928249
31. Segre E, Pigozzi L, Lison D, Pivetta E, Bosco O, Vizio B, et al. May thrombopoietin be a useful marker of sepsis severity assessment in patients with SIRS entering the emergency department? Clin Chem Lab Med. 2014; 52(10):1479–83. https://doi.org/10.1515/cclm-2014-0219 PMID: 24887960
32. Zakynthinos SG, Papanikolaou S, Theodoridis T, Zakynthinos EG, Christopoulou-Kokkinou V, Katsaris G, et al. Sepsis severity is the major determinant of circulating thrombopoietin levels in septic patients. Crit Care Med. 2004; 32(4):1004–10. PMID: 15071393
33. Eissa DS, El-Farrash RA. New insights into thrombopoiesis in neonatal sepsis. Platelets. 2013; 24 (2):122–8. https://doi.org/10.3109/09537104.2012.696748 PMID: 22746320
34. Cremer M, Weimann A, Szekessy D, Hammer H, Buhrer C, Dame C. Low immature platelet fraction suggests decreased megakaryopoiesis in neonates with sepsis or necrotizing enterocolitis. J Perinatol. 2013; 33(8):622–6. https://doi.org/10.1038/jp.2013.21 PMID: 23448941
35. Bozza FA, Salluh JI, Japiassu AM, Soares M, Assis EF, Gomes RN, et al. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care. 2007; 11(2):R49. https://doi.org/10.1186/ cc5783 PMID: 17448250
36. Ishiguro A, Suzuki Y, Mito M, Shimbo T, Matsubara K, Kato T, et al. Elevation of serum thrombopoietin precedes thrombocytosis in acute infections. Br J Haematol. 2002; 116(3):612–8. PMID: 11849220
37. Kaushansky K. The molecular mechanisms that control thrombopoiesis. J Clin Invest. 2005; 115 (12):3339–47. https://doi.org/10.1172/JCI26674 PMID: 16322778
38. Stohlawetz P, Folman CC, von dem Borne AE, Pernerstorfer T, Eichler HG, Panzer S, et al. Effects of endotoxemia on thrombopoiesis in men. Thromb Haemost. 1999; 81(4):613–7. PMID: 10235449
39. Kaser A, Brandacher G, Steurer W, Kaser S, Offner FA, Zoller H, et al. Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood. 2001; 98(9):2720–5. PMID: 11675343
40. Cerutti A, Custodi P, Mduranti, Cazzola M, Balduini CL. Circulating thrombopoietin in reactive conditions behaves like an acute phase reactant. Clin Lab Haematol. 1999; 21(4):271–5. PMID: 10583330
41. Buyse S, Teixeira L, Galicier L, Mariotte E, Lemiale V, Seguin A, et al. Critical care management of patients with hemophagocytic lymphohistiocytosis. Intensive Care Med. 2010; 36(10):1695–702. https://doi.org/10.1007/s00134-010-1936-z PMID: 20532477
42. Inai K, Noriki S, Iwasaki H, Naiki H. Risk factor analysis for bone marrow histiocytic hyperplasia with hemophagocytosis: an autopsy study. Virchows Arch. 2014; 465(1):109–18. https://doi.org/10.1007/ s00428-014-1592-8 PMID: 24852692
43. Kinasewitz GT, Yan SB, Basson B, Comp P, Russell JA, Cariou A, et al. Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative microorganism [ISRCTN74215569]. Crit Care. 2004; 8(2):R82–90. https://doi.org/10.1186/cc2459 PMID: 15025782
44. Dhainaut JF, Shorr AF, Macias WL, Kollef MJ, Levi M, Reinhart K, et al. Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure. Crit Care Med. 2005; 33(2):341–8. PMID: 15699837
45. Bat T, Leitman SF, Calvo KR, Chauvet D, Dunbar CE. Measurement of the absolute immature platelet number reflects marrow production and is not impacted by platelet transfusion. Transfusion. 2013; 53 (6):1201–4. https://doi.org/10.1111/j.1537-2995.2012.03918.x PMID: 23043309